Alivus Sets Up Brazil Subsidiary with R$500K Capital
Alivus Life Sciences Ltd has incorporated a wholly-owned subsidiary in Brazil. The subsidiary, Alivus Life Sciences Do Brasil Ltda, has R$500,000 authorized capital. Source: BSE
Stock news timeline · ALIVUS
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
Showing 4 of 4 updates · Newest first
Change the keyword or sentiment above, then click Apply.
Alivus Life Sciences Ltd has incorporated a wholly-owned subsidiary in Brazil. The subsidiary, Alivus Life Sciences Do Brasil Ltda, has R$500,000 authorized capital. Source: BSE
Alivus Life Sciences Ltd announces analyst/investor meetings on Sept 9, 2026. Meetings include UTI, Kotak MF, Param Capital, and Breakout Capital in Mumbai. Source: BSE
Alivus Life Sciences Ltd (NSE:ALIVUS) goes ex-dividend on Sept 1; dividend of ₹5/share to be paid on Oct 8. The company maintains a low payout ratio (11% of profit, 24% of cash flow), ensuring dividend sustainability. Source: Simply Wall Street
Alivus Life Sciences Ltd announces investor/analyst meetings for Aug 28 to Sep 2, 2026. Meetings include virtual and in-person sessions with Mirae Asset, Emkay Global, SIMPL, and Lyptus Capital. Source: BSE